Cytosorbents (CTSO) Non-Current Assets (2010 - 2026)

Cytosorbents has reported Non-Current Assets for 17 years, with the latest figure at $22.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 10.11% year-over-year to $22.8 million; the trailing twelve-month figure through Mar 2026 stood at $95.8 million (down 15.83% YoY), and the FY2025 full-year result was $23.5 million, down 8.62% from the prior year.
• Non-Current Assets for Q1 2026 stood at $22.8 million, down from $23.5 million in the prior quarter.
• The five-year high for Non-Current Assets was $31.5 million in Q2 2024, with the low at $22.8 million in Q1 2026.
• Historically, Non-Current Assets has averaged $27.5 million across 5 years, with a median of $27.6 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets jumped 249.53% — and 2025, when it decreased 21.69%.
• Cytosorbents' Non-Current Assets stood at $29.5 million in 2022, then slipped by 6.49% to $27.6 million in 2023, then fell by 6.49% to $25.8 million in 2024, then slipped by 8.62% to $23.5 million in 2025, then retreated by 3.16% to $22.8 million in 2026.
• The last three Non-Current Assets figures came in at $22.8 million (Q1 2026), $23.5 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.